New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
11:05 EDTVRSN, SIMG, IPXL, MEET, CACQHigh option volume stocks: SIMG CACQ IPXL VRSN MEET
News For SIMG;CACQ;IPXL;VRSN;MEET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 11, 2015
19:15 EDTIPXLOn The Fly: After Hours Movers
Subscribe for More Information
16:43 EDTIPXLImpax performs GMP, pre-approval inspections of Impax Hayward facility
Subscribe for More Information
16:15 EDTIPXLImpax says FDA issued Form 483 after facility inspection
Subscribe for More Information
16:14 EDTIPXLImpax reaffirms outlook for 2015
Impax still sees 2015 adjusted gross margins as a percent of total revenue are expected to be in the mid 50% range, adjusted total research and development expenses across the generic and brand divisions of $80M-$85M and capital expenditures of $45M-$50M.
16:13 EDTIPXLImpax reports Q1 adjusted EPS 9c, consensus 18c
Reports Q1 revenue $143.1M, consensus $146.13M. The company said, "This quarter's revenues were negatively impacted by the later than anticipated close of the Tower acquisition, the delayed launch of lamotrigine ODT, which was launched in April due to delayed receipt of inventory from our supplier, and the deferred recognition of product sales from the launch of RYTARY. In addition, product sales mix in the combined portfolio as well as costs related to successfully launching RYTARY and the financing of the Tower acquisition led to a reduction in our first quarter earnings."
15:00 EDTIPXLNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use